Norges Bank Relay Therapeutics, Inc. Transaction History

Norges Bank

  • $772 Billion
  • Q2 2025

A detailed history of Norges Bank transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Norges Bank holds 835,874 shares of RLAY stock, worth $2.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
835,874
Holding current value
$2.8 Million
% of portfolio
0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025
BUY
$2.0 - $3.49 $1.67 Million - $2.92 Million
835,874 New
835,874 $2.89 Million
Q4 2024

Feb 12, 2025
BUY
$4.12 - $6.8 $23.8 Million - $39.3 Million
5,781,878 New
5,781,878 $23.8 Million
Q2 2024

Aug 14, 2024
BUY
$5.9 - $8.02 $19.6 Million - $26.6 Million
3,319,342 New
3,319,342 $21.6 Million
Q1 2024

May 14, 2025
BUY
$7.5 - $12.07 $25.4 Million - $40.9 Million
3,392,625 New
3,392,625 $28.2 Million
Q4 2023

Feb 09, 2024
BUY
$6.01 - $11.48 $18.4 Million - $35.2 Million
3,068,973 New
3,068,973 $33.8 Million
Q3 2023

Nov 13, 2024
BUY
$8.24 - $12.97 $12.4 Million - $19.5 Million
1,506,828 New
1,506,828 $12.7 Million
Q3 2023

Nov 13, 2023
SELL
$8.24 - $12.97 $14.3 Million - $22.4 Million
-1,730,687 Closed
0 $0
Q2 2023

Aug 14, 2024
SELL
$9.99 - $18.27 $17 Million - $31.2 Million
-1,705,558 Reduced 51.38%
1,613,784 $20.3 Million
Q2 2023

Aug 14, 2023
SELL
$9.99 - $18.27 $14.2 Million - $25.9 Million
-1,417,188 Closed
0 $0
Q1 2023

May 15, 2024
BUY
$15.0 - $22.76 $24.2 Million - $36.7 Million
1,613,784 New
1,613,784 $26.6 Million
Q4 2022

Feb 14, 2023
BUY
$14.16 - $24.02 $25.3 Million - $43 Million
1,788,323 New
1,788,323 $26.7 Million
Q3 2022

Nov 13, 2023
BUY
$18.07 - $31.37 $31.3 Million - $54.3 Million
1,730,687 New
1,730,687 $38.7 Million
Q2 2022

Aug 14, 2023
BUY
$13.31 - $34.88 $18.9 Million - $49.4 Million
1,417,188 New
1,417,188 $23.7 Million
Q1 2022

May 12, 2023
SELL
$20.26 - $32.36 $17.2 Million - $27.5 Million
-850,397 Reduced 47.55%
937,926 $28.1 Million
Q1 2022

May 09, 2022
SELL
$20.26 - $32.36 $16.6 Million - $26.5 Million
-820,000 Closed
0 $0
Q4 2021

Mar 09, 2022
BUY
$26.0 - $37.03 $21.3 Million - $30.4 Million
820,000 New
820,000 $25.2 Million
Q3 2021

Nov 14, 2022
BUY
$29.75 - $37.99 $14.8 Million - $18.9 Million
497,765 New
497,765 $15.7 Million
Q3 2021

Nov 05, 2021
SELL
$29.75 - $37.99 $6.86 Million - $8.76 Million
-230,630 Closed
0 $0
Q2 2021

Aug 15, 2022
BUY
$27.5 - $38.19 $6.34 Million - $8.81 Million
230,630 New
230,630 $8.44 Million
Q2 2021

Aug 10, 2021
SELL
$27.5 - $38.19 $5.68 Million - $7.88 Million
-206,396 Closed
0 $0
Q1 2021

May 09, 2022
BUY
$32.52 - $61.53 $6.71 Million - $12.7 Million
206,396 New
206,396 $7.14 Million
Q1 2021

May 07, 2021
SELL
$32.52 - $61.53 $6.8 Million - $12.9 Million
-209,085 Closed
0 $0
Q4 2020

Mar 02, 2021
BUY
$35.51 - $54.03 $7.42 Million - $11.3 Million
209,085 New
209,085 $8.69 Million

Others Institutions Holding RLAY

# of Institutions
213
Shares Held
172M
Call Options Held
0
Put Options Held
36.1K
View Full List

About Relay Therapeutics, Inc.

RLAY Quotes by TradingView
  • Ticker RLAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 120,219,000
  • Market Cap $403M
  • Description
  • Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...
More about RLAY
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email